Schedule 13D ownership disclosure

Whitehawk Therapeutics, Inc.

Security class unavailable · CUSIP: 00032Q104

Event date: 2022-09-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,849,402
Percent of class
11.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-22-004355
Form type
SC 13D/A
Filer
Whitehawk Therapeutics, Inc.
CIK
CIK 1422142
Filed
Sep 26, 2022
Reporting period
Sep 22, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub